ACUITY-PCI: one drug does not fit all (Q79971277)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17368130 AND SRC:MED&resulttype=core&format=json

27 December 2019

title

ACUITY-PCI: one drug does not fit all (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17368130 AND SRC:MED&resulttype=core&format=json

27 December 2019

1

Ron Waksman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17368130 AND SRC:MED&resulttype=core&format=json

27 December 2019

language of work or name

English

0 references

publication date

1 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17368130 AND SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17368130 AND SRC:MED&resulttype=core&format=json

27 December 2019

volume

369

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17368130 AND SRC:MED&resulttype=core&format=json

27 December 2019

issue

9565

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17368130 AND SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

881-882

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17368130 AND SRC:MED&resulttype=core&format=json

Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(07)60421-8

7 January 2021

Bivalirudin for patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(07)60421-8

7 January 2021

Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(07)60421-8

7 January 2021

Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin,

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(07)60421-8

7 January 2021

Comparison of fondaparinux and enoxaparin in acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(07)60421-8

7 January 2021

Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(07)60421-8

7 January 2021

Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(07)60421-8

7 January 2021

10.1016/S0140-6736(07)60421-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17368130 AND SRC:MED&resulttype=core&format=json

27 December 2019

1 reference